Tabakfre
Product Images NDC 55138-017

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Tabakfre (NDC 55138-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Integra Health International, S.a. De C.v., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (Drvapelabel)

Image Description (Drvapelabel)
The text describes a drug, consisting of equal amounts of 80 plant-derived ingredients in varying potencies. It is marketed to temporarily alleviate symptoms of tobacco cravings including nausea, anxiety, insomnia, and other symptoms. The drug is recommended for use by adults aged 18 and above, should be used 5 days per week, and preferably as per the directions given on the bottle. The drug bottle comes with a dropper for measuring the required amount of medicine per use. The text also mentions the use of an atomizer for creating fine mist sprays for relief of symptoms. The drug is not recommended for children and pregnant and nursing women. It also carries some warnings and instructions on precautionary measures to be taken while using the drug. Additionally, the text briefly describes the Dr. Vape logo and the history of Vapo-Cresolene, one of the first vaporizers used for medicinal purposes.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.